We are live on ! Find out more
ANIP icon

ANI Pharmaceuticals
ANIP

106 hedge funds and large institutions have $263M invested in ANI Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 46 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more capital invested

Capital invested by funds: $214M → $263M (+$49.1M)

4% more call options, than puts

Call options by funds: $415K | Put options by funds: $400K

0.63% less ownership

Funds ownership: 59.68% → 59.05% (-0.63%)

9% less funds holding

Funds holding: 117 → 106 (-11)

35% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 46

48% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 21

Holders
106
Holders Change
-11
Holders Change %
-9.4%
% of All Funds
1.86%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
30
Reduced
46
Closed
21
Calls
$415K
Puts
$400K
Net Calls
+$15K
Net Calls Change
-$308K

Top Buyers

1
State Street
State Street
Massachusetts
+$2.51M
2
BlackRock
BlackRock
New York
+$1.94M
3
FWSM
First Wilshire Securities Management
California
+$1.85M
4
Victory Capital Management
Victory Capital Management
Texas
+$1.81M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.75M

Top Sellers

1
Man Group
Man Group
United Kingdom
-$2.06M
2
Russell Investments Group
Russell Investments Group
United Kingdom
-$1.85M
3
Morgan Stanley
Morgan Stanley
New York
-$1.59M
4
Renaissance Technologies
Renaissance Technologies
New York
-$1.3M
5
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$1.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$59.7M +$1.94M +62,057 +4%
Vanguard Group
2
Vanguard Group
Pennsylvania
$23.8M +$1.75M +55,783 +9%
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$14.7M -$606K -19,340 -5%
State Street
4
State Street
Massachusetts
$14.3M +$2.51M +80,083 +25%
ICOM
5
Investment Counselors of Maryland
Maryland
$12.7M +$381K +12,162 +4%
Goldman Sachs
6
Goldman Sachs
New York
$12.2M -$130K -4,160 -1%
TSW
7
Thompson Siegel & Walmsley
Virginia
$11.9M -$134K -4,268 -1%
Federated Hermes
8
Federated Hermes
Pennsylvania
$9.49M -$382K -12,208 -4%
Ameriprise
9
Ameriprise
Minnesota
$8.79M +$303K +9,687 +4%
FWSM
10
First Wilshire Securities Management
California
$7.95M +$1.85M +59,166 +37%
Russell Investments Group
11
Russell Investments Group
United Kingdom
$6.29M -$1.85M -59,114 -25%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$5.78M +$614K +19,600 +14%
Deutsche Bank
13
Deutsche Bank
Germany
$4.24M -$327K -10,434 -8%
Northern Trust
14
Northern Trust
Illinois
$4.23M -$239K -7,639 -6%
Renaissance Technologies
15
Renaissance Technologies
New York
$4.16M -$1.3M -41,502 -26%
Morgan Stanley
16
Morgan Stanley
New York
$3.93M -$1.59M -50,828 -32%
RIM
17
Ranger Investment Management
Texas
$3.81M -$44.5K -1,421 -1%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$3.65M -$89.5K -2,857 -3%
LSV Asset Management
19
LSV Asset Management
Illinois
$3.11M +$654K +20,886 +32%
Principal Financial Group
20
Principal Financial Group
Iowa
$2.7M +$19K +607 +0.8%
Invesco
21
Invesco
Georgia
$2.54M +$299K +9,558 +16%
Prudential Financial
22
Prudential Financial
New Jersey
$2.46M +$804K +25,685 +61%
Assenagon Asset Management
23
Assenagon Asset Management
Luxembourg
$2.29M +$323K +10,332 +19%
Two Sigma Investments
24
Two Sigma Investments
New York
$2.28M -$564K -18,016 -22%
Charles Schwab
25
Charles Schwab
California
$2.15M -$151K -4,816 -8%
1
2 3 4 5

ANIP Hedge Fund Activity: Q1 2021 in Review

106 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in ANI Pharmaceuticals (ANIP) for Q1 2021, worth a combined $263M — up 23% from $214M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of ANIP and 11 opened new positions — a net loss of 10 holders — while 46 trimmed existing stakes and 30 added.

The largest buyer was State Street, adding an estimated $2.51M. The largest seller was Man Group, exiting entirely with an estimated $2.06M sold.

  • 106 institutional investors held ANI Pharmaceuticals (ANIP) as of Q1 2021, down from 117 in Q4 2020.
  • Funds reported $263M of ANI Pharmaceuticals stock for Q1 2021, up 23% quarter-over-quarter.
  • 11 funds opened new ANI Pharmaceuticals positions in Q1 2021 and 21 closed out, a net change of -10 holders.
  • The largest ANI Pharmaceuticals buyer in Q1 2021 was State Street, an estimated $2.51M added.
  • The largest ANI Pharmaceuticals seller in Q1 2021 was Man Group, an estimated $2.06M sold.

Based on aggregated 13F filings for Q1 2021.